199 related articles for article (PubMed ID: 11728799)
1. Epoetin alfa in cancer patients: evidence-based guidelines.
Turner R; Anglin P; Burkes R; Couture F; Evans W; Goss G; Grimshaw R; Melosky B; Paterson A; Quirt I;
J Pain Symptom Manage; 2001 Nov; 22(5):954-65. PubMed ID: 11728799
[TBL] [Abstract][Full Text] [Related]
2. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
[TBL] [Abstract][Full Text] [Related]
3. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
[TBL] [Abstract][Full Text] [Related]
4. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.
Glaspy J; Degos L; Dicato M; Demetri GD
Oncologist; 2002; 7(2):126-35. PubMed ID: 11961196
[TBL] [Abstract][Full Text] [Related]
5. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
Glaspy J
Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
[TBL] [Abstract][Full Text] [Related]
6. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
7. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis.
Jones M; Schenkel B; Just J; Fallowfield L
Cancer; 2004 Oct; 101(8):1720-32. PubMed ID: 15386341
[TBL] [Abstract][Full Text] [Related]
8. Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.
Straus DJ
Clin Lymphoma; 2003 Aug; 4 Suppl 1():S13-7. PubMed ID: 14556671
[TBL] [Abstract][Full Text] [Related]
9. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
[TBL] [Abstract][Full Text] [Related]
10. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
[TBL] [Abstract][Full Text] [Related]
12. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa in patients not on chemotherapy - Canadian data.
Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F
Semin Oncol; 2002 Jun; 29(3 Suppl 8):75-80. PubMed ID: 12082658
[TBL] [Abstract][Full Text] [Related]
14. The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
Itri LM
Semin Oncol; 2002 Jun; 29(3 Suppl 8):81-7. PubMed ID: 12082659
[TBL] [Abstract][Full Text] [Related]
15. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
16. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
17. The effect of Epoetin alfa on quality of life in anemic cancer patients.
Cella D; Bron D
Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
[TBL] [Abstract][Full Text] [Related]
18. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
Glaspy J; Bukowski R; Steinberg D; Taylor C; Tchekmedyian S; Vadhan-Raj S
J Clin Oncol; 1997 Mar; 15(3):1218-34. PubMed ID: 9060566
[TBL] [Abstract][Full Text] [Related]
19. Managing cancer-related anaemia with epoetin alfa.
Itri LM
Nephrol Dial Transplant; 2002; 17 Suppl 1():73-7. PubMed ID: 11812917
[TBL] [Abstract][Full Text] [Related]
20. Management of cancer-related anemia: epoetin alfa and quality of life.
Soignet S
Semin Hematol; 2000 Oct; 37(4 Suppl 6):9-13. PubMed ID: 11068950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
